Bessemer Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bessemer Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43K	Hold	1,012	–	–	﹤0.01%	1739
2026 Q1	$26K	Hold	1,012	–	–	﹤0.01%	1849
2025 Q4	$29K	Buy	1,012 +1,000	+8,333%	+$30K	﹤0.01%	1776
2025 Q3	$0	Hold	12	–	–	﹤0.01%	2479
2025 Q2	$0	Hold	12	–	–	﹤0.01%	2388
2025 Q1	$0	Hold	12	–	–	﹤0.01%	2431
2024 Q4	$0	Hold	12	–	–	﹤0.01%	2454
2024 Q3	$0	Sell	12 -244	-95%	-$6.21K	﹤0.01%	2610
2024 Q2	$6K	Hold	256	–	–	﹤0.01%	1642
2024 Q1	$7K	Hold	256	–	–	﹤0.01%	1622
2023 Q4	$8K	Sell	256 -150	-37%	-$4.08K	﹤0.01%	1626
2023 Q3	$11K	Buy	406 +150	+59%	+$4.9K	﹤0.01%	1553
2023 Q2	$8K	Hold	256	–	–	﹤0.01%	1689
2023 Q1	$7K	Hold	256	–	–	﹤0.01%	1520
2022 Q4	$7K	Hold	256	–	–	﹤0.01%	1483
2022 Q3	$8K	Sell	256 -400	-61%	-$14.7K	﹤0.01%	1594
2022 Q2	$21K	Buy	656 +400	+156%	+$14K	﹤0.01%	1246
2022 Q1	$12K	Hold	256	–	–	﹤0.01%	1346
2021 Q4	$16K	Hold	256	–	–	﹤0.01%	1313
2021 Q3	$19K	Buy	256 +12	+5%	+$1.01K	﹤0.01%	1237
2021 Q2	$23K	Buy	+244	New	+$20.7K	﹤0.01%	1209

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bessemer Group's ARKG Position: Q2 2026 in Review

Bessemer Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 1,012 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Bessemer Group first reported a position in ARKG in Q2 2021 and has held it in 21 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Bessemer Group held 1,012 shares of ARK Genomic Revolution ETF worth $43K as of Q2 2026.
Bessemer Group left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1739 holding.
Bessemer Group first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 21 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.